Viewing Study NCT02660866


Ignite Creation Date: 2025-12-24 @ 4:08 PM
Ignite Modification Date: 2026-02-22 @ 5:24 PM
Study NCT ID: NCT02660866
Status: UNKNOWN
Last Update Posted: 2018-05-29
First Post: 2015-12-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)
Sponsor: North Texas Veterans Healthcare System
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Peripheral Arterial Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None intermittent claudication View
None randomized controlled trial View